» Authors » Yuichi Ikarashi

Yuichi Ikarashi

Explore the profile of Yuichi Ikarashi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 71
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Koroku M, Omori T, Kambayashi H, Murasugi S, Kuriyama T, Ikarashi Y, et al.
Intest Res . 2021 Apr; 20(1):150-155. PMID: 33902268
Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have...
2.
Arimura K, Tagaya E, Kikuchi K, Mitsuda T, Yasuda G, Azuma H, et al.
Respir Investig . 2021 Feb; 59(3):356-359. PMID: 33579647
Hospital-acquired severe acute respiratory virus coronavirus 2 (SARS-CoV-2) infection is a healthcare challenge. We hypothesized that polymerase chain reaction testing of symptomatic triaged outpatients and all inpatients before hospitalization in...
3.
Kodama K, Ichihara A, Seki Y, Ikarashi Y, Sagawa T, Kogiso T, et al.
Can J Gastroenterol Hepatol . 2020 Oct; 2020:8814435. PMID: 33102399
Background: Hypopituitarism and hypothalamic disorders, which induce central obesity and appetite disorder, are associated with nonalcoholic fatty liver disease (NAFLD). We retrospectively analyzed the clinical features of NAFLD patients with...
4.
Nishimuta M, Masui K, Yamamoto T, Ikarashi Y, Tokushige K, Hashimoto E, et al.
Neuropathology . 2018 Feb; 38(3):321-328. PMID: 29468756
We present a case of hepatolenticular degeneration, so-called Wilson's disease (WD), in a 31-year-old Japanese man with broader deposition of copper in the liver, kidney and brain. The liver showed...
5.
Ikarashi Y, Kodama K, Taniai M, Hashimoto E, Tokushige K
Intern Med . 2017 Dec; 57(8):1065-1070. PMID: 29269684
Objective The rate of platelet count reduction appears to differ among different liver diseases. In the present study, we investigated the difference in the platelet counts of patients with nonalcoholic...
6.
Kogiso T, Kobayashi M, Yamamoto K, Ikarashi Y, Kodama K, Taniai M, et al.
Intern Med . 2017 Sep; 56(22):2993-3001. PMID: 28943585
Objective Hyponatremia is frequently observed in patients with decompensated liver cirrhosis and it is also related to a poor prognosis. The vasopressin V2-receptor antagonist tolvaptan is used to treat cirrhotic...
7.
Kogiso T, Hashimoto E, Ito T, Hara T, Ikarashi Y, Kodama K, et al.
Intern Med . 2016 Oct; 55(20):2957-2963. PMID: 27746432
A 56-year-old man was diagnosed with aplastic anemia and paroxysmal nocturnal hemoglobinuria at 43 years of age and treatment with cyclosporin A was started. Liver cirrhosis, ascites, and thrombus in...
8.
Kogiso T, Yamamoto K, Kobayashi M, Ikarashi Y, Kodama K, Taniai M, et al.
Hepatol Res . 2016 Sep; 47(9):835-844. PMID: 27670393
Aim: The vasopressin V2 receptor antagonist tolvaptan has been used for the treatment of cirrhotic patients with ascites; however, no predictor of efficacy and prognosis has been developed. We evaluated...
9.
Ikarashi Y, Kogiso T, Hashimoto E, Yamamoto K, Kodama K, Taniai M, et al.
Hepatol Res . 2016 Mar; 47(3):E201-E209. PMID: 27027269
Poorly controlled diabetes mellitus (DM) patients sometimes show serum transaminase elevations due to steatohepatitis. However, we experienced four cases with type 1 DM with sharp elevations in serum transaminases that...
10.
Kogiso T, Hashimoto E, Ikarashi Y, Kodama K, Taniai M, Torii N, et al.
Clin J Gastroenterol . 2015 Sep; 8(5):323-9. PMID: 26342292
Re-infection by the hepatitis C virus (HCV) occurs rapidly after liver transplantation (LT), and spontaneous clearance of HCV is rare under immunosuppressive conditions. Here, we report on two patients who...